comparemela.com

Page 5 - Labcentral Ignite News Today : Breaking News, Live Updates & Top Stories | Vimarsana

LabCentral Releases 2020 Impact Report: Companies Raised $3 7 Billion in Funding and 33% of 2020 Massachusetts Bio-Pharma IPOs Started in the LabCentral Network

Share this article CAMBRIDGE, Mass., April 8, 2021 /PRNewswire/   LabCentral, a network of premier laboratory and co-working facilities for high-potential biotech start-ups, today released its annual  Impact Report detailing the influence of its resident and alumni companies on the local and national life sciences and biotech industry in terms of funding, job creation, economic development, IPOs and new programs from the past year. The 2020 Impact Report is available to view and download from LabCentral s website, in addition to The 2020 Impact Report also details the technical and scientific pivots made by several LabCentral resident and alumni companies to address the COVID-19 pandemic, as well as LabCentral s role in the formation of the Cambridge Consortium for Rapid COVID-19 Tests (CCRCT).

LabCentral Announces $22 4 Million in Committed Funding for LabCentral 238 including New Sponsors Thermo Fisher Scientific and Waters Corporation

Share this article Share this article CAMBRIDGE, Mass., Feb. 18, 2021 /PRNewswire/  LabCentral, the first-of-its-kind shared laboratory space designed as a launchpad for high-potential biotech startups, today announced a total of $22.4 million in sponsorship commitments for LabCentral 238, a fully functional life sciences laboratory with a focus on scale-up bio-manufacturing. Thermo Fisher Scientific and Waters Corporation join Astellas and the Massachusetts Life Sciences Center (MSLC) as sponsors. Part of the Massachusetts Institute of Technology s (MIT) South of Main Street (SoMa) Development in the heart of Kendall Square s innovation hub, LabCentral 238 is currently under construction and is expected to open in November 2021. LabCentral 238 co-working laboratory focused on bio-manufacturing (rendering by Encore and Perkins+Will)

LabCentral Launches LabCentral Ignite - New Initiative to Advance Life Sciences Innovation by Expanding and Diversifying the Talent Base for the Biotech Industry

Share this article Share this article CAMBRIDGE, Mass., Jan. 13, 2021 /PRNewswire/  LabCentral, the first-of-its-kind shared laboratory space designed as a launchpad for high-potential biotech startups, today announced LabCentral Ignite, a new initiative with the goal of enhancing regional biotech innovation by stimulating a robust pipeline of diverse, qualified talent. Through internal programming and grants to non-profits focused on STEM education, workforce training and entrepreneurial development, LabCentral Ignite will facilitate broader access to the biotech industry, with emphasis on socio-economically disadvantaged, underserved and under-represented individuals and communities. To oversee the program s growth and development, LabCentral has promoted Krista Licata to the role of managing director of LabCentral Ignite. She has spent the past seven years with LabCentral in a variety of roles, most recently serving as the senior director of site operations.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.